EUVIMEDEUVIMED entdecken
Crossref

ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer

Yang Luo, Hao Li, Hongsheng Fang, Tingyue Gong, Yongheng Zhao iD, Wenyan Cao, Minhao Yu, Tingfeng Wang, Haiping Lin, Ming Zhong

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Yang Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inducible T-Cell Co-Stimulator Protein, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Jinhua Science and Technology Planning Project, National Natural Science Foundation of China, Shanghai Shenkang Clinical Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inducible Co-Stimulator (ICOS), as a T-cell–specific costimulatory receptor that enhances T-cell responses to foreign antigens, plays a crucial role in cancer immunity. However, its role in MSS/pMMR colorectal cancer (CRC) remains unclear. In this study, we demonstrated that ICOS expression decreases as the tumor stages advance and that high ICOS expression is associated with a favorable prognosis in MSS/pMMR CRC. Mechanistically, ICOS promoted the secretion of IFN-γ, TNF-α, and IL-12 in CD4+ T cells through the Akt/STAT1/T-bet axis, leading to the inhibition of MSS/pMMR-CRC-cell proliferation. Importantly, ICOS+ CD4+ T cells enhanced tumor responses to anti-PD-1 therapy in MSS/pMMR CRC. In conclusion, this study revealed that ICOS mediates antitumor immunity by promoting the secretion of cancer-suppressive cytokines. It also suggests that activation of ICOS serves a potential therapeutic strategy for MSS/pMMR CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsInducible T-Cell Co-Stimulator ProteinCD4-Positive T-LymphocytesHumansProto-Oncogene Proteins c-aktMiceAnimalsT-Box Domain ProteinsT-bet Transcription FactorSTAT1 Transcription FactorCell Line, TumorSignal TransductionFemaleMaleCell Proliferation

Stichwörter der Autor:innen

ICOST-betanti-PD-1 therapyantitumor immunitycolorectal cancer

Substanzen

Inducible T-Cell Co-Stimulator ProteinProto-Oncogene Proteins c-aktT-Box Domain ProteinsT-bet Transcription FactorSTAT1 Transcription FactorICOS protein, humanSTAT1 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center.
  • Department of Hepatopancreatobiliary Surgery, Jinhua Central Hospital, Teaching Hospital of Mathematical Medicine College, Zhejiang Normal University, Zhejiang, China.

ORCID-Profile: Yongheng Zhao

Förderung

  • Jinhua Science and Technology Planning Project
  • National Natural Science Foundation of China
  • Shanghai Shenkang Clinical Development Center
  • Jinhua Science and Technology Planning

Zitieren

APA

Luo, Y., Li, H., Fang, H., Gong, T., Zhao, Y., Cao, W., Yu, M., Wang, T., Lin, H., & Zhong, M. (2025). ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf040

Vancouver

Luo Y, Li H, Fang H, Gong T, Zhao Y, Cao W, et al. ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf040

BibTeX
@article{Luo2025,
  author = {Luo, Yang and Li, Hao and Fang, Hongsheng and Gong, Tingyue and Zhao, Yongheng and Cao, Wenyan and Yu, Minhao and Wang, Tingfeng and Lin, Haiping and Zhong, Ming},
  title = {ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf040}
}
Kostenlos starten →